COVID-19 SARS-CoV-2 Screening Protocol

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

June 23, 2021

Study Completion Date

July 9, 2021

Conditions
Covid19
Trial Locations (1)

E1 2AX

hVIVO Services Ltd, QMB Bioenterprise building, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hvivo

INDUSTRY

lead

Imperial College London

OTHER

NCT04740320 - COVID-19 SARS-CoV-2 Screening Protocol | Biotech Hunter | Biotech Hunter